HomeUncategorizedGilead Lawsuit Takes Aim at Scheme, 'Staggering in Scope,' to Obtain, Re-sell HIV Drugs – Times of San Diego
October 3, 2022
Gilead Lawsuit Takes Aim at Scheme, 'Staggering in Scope,' to Obtain, Re-sell HIV Drugs – Times of San Diego
Times of San Diego Local News and Opinion for San Diego A federal judge has frozen the assets of dozens of people and entities accused of operating a nationwide scheme to distribute counterfeit bottles of Gilead Sciences Inc. HIV drugs. The widespread case, which Gilead described in court papers as “staggering in scope,” involves two alleged “kingpins.” Gilead, which has been pursuing alleged counterfeiters in a civil lawsuit since last year, said in a court filing unsealed on Wednesday that the alleged illicit operation is responsible for sales of hundreds of millions of dollars of counterfeit bottles of its top sellers Descovy, Genvoya and Biktarvy, and other medicines. An order to freeze assets, by U.S. District Judge Ann Donnelly in New York, also unsealed on Wednesday, targets more than 50 defendants newly added to Gilead’s suit. Many counterfeit bottles contain antiviral pills manufactured by Gilead, but illegally bought off the street and repackaged, while some have been found to contain other, potentially dangerous drugs, including the powerful antipsychotic Seroquel, Gilead has said. We’ll send you the top local news stories every morning at 8 a.m.
By clicking subscribe, you agree to share your email address with Times of San Diego to receive our free newsletter and breaking news alerts. We won’t use your email for any other purpose, and you can opt out at any time via an unsubscribe link. HIV drugs accounted for $7.6 billion of Gilead’s $12.6 billion revenue in the first half of the year. The company in January warned that more than $250 million of counterfeit drugs had been sold over the last two years, and said it had identified more than 85,000 bottles that were fake or tampered with. The newly added defendants include alleged “kingpin” Lazaro Roberto Hernandez, who was arrested on drug counterfeiting and money laundering charges in June as part of a related federal investigation and remains under house arrest. The other alleged kingpin, Armando Herrera, lives in Florida. “Gilead’s ongoing investigation revealed that these two kingpins directed the initial sale of the counterfeits through suppliers created solely to sell counterfeit medications,” the company said in a statement on Wednesday. Gilead said it had identified the two men, who took elaborate steps to conceal their identities, by matching approximate locations of their disposable burner cell phones with flight records. The Foster City, California-based company, which has office in Oceanside, first announced it was pursuing counterfeiters in August 2021, shortly after filing its lawsuit. The case also includes alleged mid-level leaders and a complex web of shell companies, distributors and pharmacies, along with so-called collectors. The latter group pay cash on the street for the bottles used in the scheme, often acquiring them from people who are homeless or suffering from drug addiction, Gilead said. (Reporting By Brendan Pierson in New York and Akriti Sharma in Bengaluru, editing by Bill Berkrot and Leslie Adler) – Reuters With the generous support of readers like you, Times of San Diego publishes timely and accurate news coverage for a better-informed community. Help us grow with a monthly contribution. Our free newsletter is delivered at 8 a.m. daily.